Bio-Rad Laboratories, Inc. is a global leader in developing, manufacturing, and marketing a broad range of innovative products for the life science research and clinical diagnostic markets. With a focus on quality and customer service for over 65 years, our products advance the discovery process and improve healthcare. Our customers are university and research institutions, hospitals, public health, and commercial laboratories, biotechnology, pharmaceutical, as well as applied laboratories that include food safety and environmental quality. Founded in 1952, Bio-Rad is based in Hercules, California, and has a global network of operations with more than 8,000 employees worldwide. Bio-Rad had revenues exceeding $2.2 billion in 2018.
Main tasks attributed in the A-PATCH project:
As an end-user and potential commercialization partner, the main tasks attributed to BRL in the project include:
- Lead WP1
- Participate and contribute to WP2, WP5, WP6, WP7
- Participate in project definition of requirements, use cases, benchmarks, and architecture
- Participate in validation, dissemination, and exploitation of the project
- BRL will advise the consortium regarding developments which can demonstrate clear compliance with applicable Good Laboratory Practice / Good Clinical Practice / Good Manufacturing Practice and ensure that the products will be consistent with ISO and other regulations (both national and European).
- BRL will direct the exploitation plans and activities
- BRL will conduct a market survey regarding the use of the patches and build a business case and exploitation strategy for the developed product.
- This will link with involvement in WP6, the Validation and Evaluation work package, which includes both health technology assessment and cost-benefit analysis.
Based on the above, BRL will collaborate with the manufacturing and industrial partners to lead the design plans for mass production, which will feed into the exploitation planning.
Mr. Matthieu Ferret
Business Unit Marketing Manager
Since 2013 Matthieu is Bio-Rad’s Marketing Manager, Unitary testing Business Unit, Infectious Disease Division, Bio-Rad, France. His responsibilities include worldwide marketing activities management, and development of Unitary assays portfolio & POC assays automation (Retrovirus, Infectious Mononucleosis, Prenatal and congenital Disease, Respiratory Disease, Febrile and Tropical Disease, Fungal Disease, Tuberculosis). His prior positions at Bio-Rad were: 2006-2013: Retrovirus International Product Manager, Blood Virus Division; 2002-2006: System & Software International Product Manager, Food Sciences Division. Previously Matthieu had been Communication and Training manager, Systems applications engineer and Sales representative at Ortho-Clinical Diagnostics France from 1994 till 2002; and Sales representative at Sanofi Diagnostics Pasteur France from 1991 till 1994. Between 1990-1991 Matthieu served under the Chiefs of Staff of the Army Air / Balard Air base 118 Paris 15. He Holds a Master of Biochemistry the Sciences University (Rennes), with majors in mathematics, physics, and biology, a Licence of Biochemistry Sciences university (Rennes) and DEUG B (General Biology University Degree).
Dr. Stephane Rihet
Research & Development Manager
Since 2015, Stephane is R&D Manager, Infectious Disease Division at Bio-Rad, France, working on the development of TB VOC program as the main focus, and other collaborative programs in Infectious Diseases (Sepsis, Platelets contamination, New IVDR registration program). Between 2005-2015 Stephane worked as R&D Manager in the Molecular Biology Unit, managing real-time qPCR R&D activities and developing 13 Dx tests including Sample Prep Reagents and integration of reagents on Sample Prep automated system. From 2003 till 2005 he was R&D Project Leader working on the development of a quantitative real-time PCR HPV multiplex test and external scientific collaboration on new prognostic markers of cervical cancer. Prior to Bio-Rad, he worked as Molecular Biology Engineer at Roche Diagnostic and as Project Manager (Post Doc) at Institut Curie, Cancer Unit. Stephane holds a Ph.D. (1997) in Immunology and Molecular Biology and an MSc, (DEA) GEBM – Engineering Enzymatic Bioconversion and Microbiology (1993), both from the Amiens University of Technology, Compiègne.
Dr. Patrice Sarfati
Research & Development Director
Since 2013, Patrice is Intl. R&D Director, Infectious Disease Division, at Bio-Rad France, leading operational management of the R&D dept. in Infectious Diseases (100+ FTE), with worldwide responsibilities for molecular techniques, Immunology and bacteriology / Elisa platforms, classical microbiological media / AST expert & epidemiology system / HIV, HCV, Dengue Rapid tests / Mycology Ag & Ab tests / Virology tests for Blood banking closed systems. From 2003 till 2013, Patrice was Intl. R&D Director, Clinical Microbiology Division, leading operational management of the R&D dept. in Infectious Diseases (30+ FTE), with worldwide responsibilities for molecular techniques, Immunology and bacteriology / Elisa platforms, classical microbiological media / AST platform Development & epidemiology system / Chromogenic media / Rapid tests. Prior positions include: 1997-2003: R&D Director, Eurobio, Toulouse and Les Ulis, France; 1992-1997: Scientific Manager / Clinical Research, LABM CEDIBIO, Toulouse, France; 1991-1992: Inserm Research Scientist – Molecular and Cellular Biology Unit. Pancreatic Cancer.
Patrice holds a Post Doc (1990) in Digestive Physiology, with specialization in Molecular Biology. CRSNG Scholarship (Lauréat au concours du Conseil de Recherche en Sciences Naturelles et en Génie) of Canada. Research Project: Early biomarkers involved in in-vitro and in-vivo tumor proliferation. CHU Rangueil, Unité INSERM 151, Toulouse, FRANCE; Ph.D. (1988) in Biology with specialization in Digestive Physiology – Cell Biology. CRSNG Scholarship (Lauréat au concours du Conseil de Recherche en Sciences Naturelles et en Génie) of Canada. Research Project: Regulation of Pancreatic function. Identification of a new pancreatic enzyme: Somatostatinase. Sherbrooke University, Sherbrooke, CANADA.
Patrice holds a Post Doc (1990) in Digestive Physiology, with specialization in Molecular Biology. CRSNG Scholarship (Lauréat au concours du Conseil de Recherche en Sciences Naturelles et en Génie) of Canada. Research Project: Early biomarkers involved in in-vitro and in-vivo tumor proliferation. CHU Rangueil, Unité INSERM 151, Toulouse, FRANCE; Ph.D. (1988) in Biology with specialization in Digestive Physiology – Cell Biology. CRSNG Scholarship (Lauréat au concours du Conseil de Recherche en Sciences Naturelles et en Génie) of Canada. Research Project: Regulation of Pancreatic function. Identification of a new pancreatic enzyme: Somatostatinase. Sherbrooke University, Sherbrooke, CANADA.
